| J9271 | Injection, pembrolizumab, 1 mg | 13,400 | $40 | $576.2K |
| J9299 | Injection, nivolumab, 1 mg | 5,940 | $20 | $142.6K |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 3,600 | $40 | $136.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 280 | $110 | $29.2K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 160 | $70 | $10.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 100 | $90 | $8.7K |
| 96367 | The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose… | 360 | $20 | $8.3K |
| 74177 | The provider performs computed tomography of the abdomen and pelvis with contrast material to diagnose the cause of abdominal or pelvic pain or other abnormalities of the internal organs. | 30 | $180 | $6.2K |
| 96417 | In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy… | 90 | $50 | $4.5K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 90 | $50 | $4.4K |